Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SRx Health Solutions (SRXH) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for SRx Health Solutions (SRXH) over the last 16 years, with Q2 2025 value amounting to $3.2 million.

  • SRx Health Solutions' Cash from Financing Activities fell 1788.6% to $3.2 million in Q2 2025 from the same period last year, while for Jun 2025 it was $3.5 million, marking a year-over-year decrease of 688.11%. This contributed to the annual value of -$5.1 million for FY2023, which is 49758.19% down from last year.
  • According to the latest figures from Q2 2025, SRx Health Solutions' Cash from Financing Activities is $3.2 million, which was down 1788.6% from -$1.2 million recorded in Q1 2025.
  • Over the past 5 years, SRx Health Solutions' Cash from Financing Activities peaked at $34.4 million during Q3 2021, and registered a low of -$4.6 million during Q2 2023.
  • In the last 5 years, SRx Health Solutions' Cash from Financing Activities had a median value of -$95500.0 in 2023 and averaged $2.3 million.
  • Its Cash from Financing Activities has fluctuated over the past 5 years, first crashed by 193466.67% in 2023, then soared by 350933.33% in 2024.
  • Quarter analysis of 5 years shows SRx Health Solutions' Cash from Financing Activities stood at -$552000.0 in 2021, then fell by 1.63% to -$561000.0 in 2022, then surged by 41.53% to -$328000.0 in 2023, then plummeted by 982.32% to -$3.6 million in 2024, then soared by 188.85% to $3.2 million in 2025.
  • Its Cash from Financing Activities was $3.2 million in Q2 2025, compared to -$1.2 million in Q1 2025 and -$3.6 million in Q4 2024.